Often, crucial clinical information, such as serum levels of tumor markers (CA19-9, AFP), lesion size and location, history of previous neoplasms, and clinical hypotheses, is not properly shared, compromising the diagnosis and, therefore, the therapeutic approach. Here, AFP is linked to neoplasm.